Product information
NAD+
1,000 mg total per pen

Information revision AEV-18B.1 · Updated . No approved instructions revision or approval date is recorded.
Identity and intended use
About NAD+
The AEVIA NAD+ presentation is a non-refillable multidose pen with a rotary selector. The specified total content is 1,000 mg of NAD+ per pen; this is not an individual dose.
The liquid volume, concentration, full formulation and dose increments have not been verified for this presentation. No application schedule is published here.
Compound identity and research context · Separate from the exact product specification
What it is
NAD+ is a coenzyme, not a peptide. It participates in cellular redox chemistry.
Biological target / research area
Cellular metabolism and NAD-related pathways.
What the research examined
Evidence context: human metabolism pilot
A small human pilot examined plasma and urine metabolites during an intravenous infusion.
Evidence limitations
This metabolic study does not establish anti-ageing, energy or cognitive benefits from AEVIA vials or pens. Precursor supplement studies are not interchangeable with NAD+ injections.
Selected references
- Pilot investigation of plasma and urine NAD+ metabolites during infusion (2019) ↗ · Reviewed 14/10/2026
Device and pack contents
The owner-confirmed presentation is a non-refillable multidose pen with a rotary selector and 1,000 mg total NAD+ per pen. This total is not an individual dose.
Accessory quantities, certification and the final bill of materials are not confirmed by the packaging image. No larger pack or vial specification is transferred to this pen.
Documentation status
Instructions and safety
NAD+ is outside the peptide research-only scope by owner instruction. This does not establish regulatory approval, approval for human administration or supply permission.
No dose, selector increment, injection sequence or administration schedule is provided. Do not infer these from the artwork or total content.
Storage, expiry and disposal
Exact-product storage conditions, in-use stability, expiry and disposal instructions have not been released. Request the applicable documentation; dates shown in visual concepts are not batch records.
Technical documents
No approved instructions-for-use document is currently available for this exact pen presentation. Product identity, formulation, liquid volume, device revision, calibration, storage and applicable document-delivery requirements must be resolved before instructions are released. A digital page does not replace any required physical leaflet.
Product documentation support
Contact the AEVIA team about your exact product label or documentation.
support@aevia.global ↗